Effect of novel dinuclear platinum(II) complexes on redox status of MOLT-4 leukemic cells

References

• Aebi H. (1984). Catalase in vitro. Meth Enzymol 105:121–6
   PubMed Web of Science ®Google Scholar
• Akaboshi M, Kawai K, Maki H, et al. (1992). The number of platinum atoms binding to DNA, RNA and protein molecules of HeLa cells treated with cisplatin at its mean lethal concentration. J Cancer Res 83:522–6
   Google Scholar
• Barcelo F, Ortiz-Lombardia M, Portugal J. (2001). Heterogenous DNA binding models of berenil. Biochim Biophys Acta 1519:175–84
   PubMed Web of Science ®Google Scholar
• Barcelo F, Portugal J. (1993). Berenil recognizes and changes the characteristics of adenine and thymine polynucleotide structures. Biophys Chem 47:251–60
   PubMed Web of Science ®Google Scholar
• Barrera G. (2012). Oxidative stress and lipid peroxidation products in cancer progression and therapy. ISRN Oncol 1:1–21
   Google Scholar
• Bielawski K, Bielawska A, Popławska B, Bołkun-Skórnicka U. (2008). Synthesis, DNA-binding affinity and cytotoxicity of the dinuclear platinum(II) complexes with berenil and amines ligands. Drug Research 65:363–70
   Google Scholar
• Bielawska A, Popławska B, Surażyński A, et al. (2010). Cytotoxic efficacy of a novel dinuclear platinum(II) complex in human breast cancer cells. Eur J Pharmacol 643:34–41
   PubMed Web of Science ®Google Scholar
• Bielawski K, Czarnomysy R, Muszyńska A, et al. (2013). Cytotoxicity and induction of apoptosis of human breast cancer cells by novel platinum (II) complex. Environ Toxicol Pharmacol 35:254–64
   PubMed Web of Science ®Google Scholar
• Biroccio A, Benassi B, Fiorentino F, Zupi G. (2004). Glutathione depletion induced by c-Myc downregulation triggers apoptosis on treatment with alkylating agents. Neoplasia 6:195–206
   PubMed Web of Science ®Google Scholar
• Brabec V, Kasparkova J. (2005). Modifications of DNA by platinum complexes Relation to resistance of tumors to platinum antitumor drugs. Drug Resistance Updates 8:131–46
   PubMed Web of Science ®Google Scholar
• Bradbury CM, Locke JE, Wei SJ, et al. (2001). Increased activator protein 1 activity as well as resistance to heat-induced radiosensitization, hydrogen peroxide, and cisplatin are inhibited by indomethacin in oxidative stress-resistant cells. Cancer Res 61:3486–92
   PubMed Web of Science ®Google Scholar
• Bradford MM. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–54
   PubMed Web of Science ®Google Scholar
• Caramelo-Nunes C, Tente T, Almeida P, et al. (2011). Specific berenil–DNA interactions: an approach for separation of plasmid isoforms by pseudo-affinity chromatography. Anal Biochem 412:153–8
   PubMed Web of Science ®Google Scholar
• Cepeda V, Fuertes MA, Castilla J, et al. (2007). Biochemical mechanisms of cisplatin cytotoxity. Anticancer Agents Med Chem 7:3–18
   PubMed Web of Science ®Google Scholar
• Cereser C, Guichard J, Drai J, et al. (2001). Quantitation of reduced and total glutathione at the femtomole level by high-performance liquid chromatography with fluorescence detection: application to red blood cells and cultured fibroblasts. J Chromatography 752:123–32
   Web of Science ®Google Scholar
• Chao MR, Wang HJ, Yen CC, et al. (2007). Simultaneous determination of N7-alkylguanines in DNA by isotope-dilution LC-tandem MS coupled with automated solid-phase extraction and its application to a small fish model. J Biochem 402:483–90
   Google Scholar
• Codreanu SG, Zhang B, Sobecki SM, et al. (2009). Global analysis of protein damage by the lipid electrophile 4-hydroxy-2-nonenal. Mol Cellular Proteomics 8:670–80
   PubMed Web of Science ®Google Scholar
• Collins JG, Wheate NJ. (2004). Potential adenine and minor groove binding platinum complexes. J Inorg Biochem 98:1578–84
   PubMed Web of Science ®Google Scholar
• Coolen SA, van Buuren B, Duchateau G, et al. (2005). Kinetics of biomarkers: biological and technical validity of isoprostanes in plasma. Amino Acids 29:429–36
   PubMedGoogle Scholar
• Denny WA. (2001). DNA minor groove alkylating agents. Curr Med Chem 8:533–44
   PubMed Web of Science ®Google Scholar
• Dizdaroglu M, Jaruga P, Rodriguez H. (2001). Measurement of 8-hydroxy-2′-deoxyguanosine in DNA by high-performance liquid chromatography-mass spectrometry: comparison with measurement by gas chromatography-mass spectrometry. Nucleic Acids Res 29:3–12
   Web of Science ®Google Scholar
• Eissa S, Seada LS. (1998). Quantitation of bcl-2 protein in bladder cancer tissue by enzyme immunoassay: comparison with Western blot and immunohistochemistry. Clin Chem 44:1423–9
   PubMed Web of Science ®Google Scholar
• Er TK, Tsai SM, Wu SH, et al. (2007). Antioxidant status and superoxide anion radical generation in acute myeloid leukemia. Clin Biochem 40:1015–19
   PubMed Web of Science ®Google Scholar
• Fernandes RS, Cotter TG. (1994). Apoptosis or necrosis: intracellular levels of glutathione iκluence mode of cell death. Biochem Pharmacol 48:675–81
   PubMed Web of Science ®Google Scholar
• Fuertes MA, Alonso C, Pérez JM. (2003). Biochemical modulation of Cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance. Chem Rev 103:645–62
   PubMed Web of Science ®Google Scholar
• Galler B, Winge D. (1983). A method for distinguishing Cu, Zn- and Mn-containing superoxide dismutases. Anal Biochem 128:86–92
   PubMed Web of Science ®Google Scholar
• Giaccone G, Herbst RS, Manegold C, et al. (2004). Gefitinib in combination with gemcitabine and cisplatin in advanced non–small-cell lung cancer: a phase III trial—INTACT 1. J Clin Oncol 22:777–84
   PubMed Web of Science ®Google Scholar
• Gonzalez VM, Perez M, Aknso C. (1997). The berenil ligand directs the DNA binding of the cytotoxic drug Pt-Berenil. J Inorgan Biochem 68/4:283–7
   Web of Science ®Google Scholar
• Handy DE, Lubos E, Yang Y, et al. (2009). Glutathione peroxidase-1 regulates mitochondrial function to modulate redox-dependent cellular responses. J Biol Chem 284:11913–21
   PubMed Web of Science ®Google Scholar
• Huang O, Deveraux QL, Maeda S, et al. (2000). Evolutionary conservation of apoptosis mechanisms: lepidopteran and baculoviral inhibitor of apoptosis proteins are inhibitors of mammalian caspase-9. PNAS 97:1427–32
   PubMed Web of Science ®Google Scholar
• Ivanovic D, Propovic A, Radulovic D. (1999). Reversed phase ion-pair HPLC determination of some water-solube vitamins in pharmaceuticals. J Pharm Biomed Anal 18:999–1004
   PubMed Web of Science ®Google Scholar
• Kawai Y, Nakao T, Kunimura N, et al. (2006). Relationship of intracellular calcium and oxygen radicals to cisplatin-related renal cell injury. J Pharmacol Sci 100:65–72
   PubMed Web of Science ®Google Scholar
• Kim HJ, Lee JH, Kim SJ, et al. (2010). Roles of NADPH oxidases in cisplatin-induced reactive oxygen species generation and ototoxicity. J Neurosci 30:3933–46
   PubMed Web of Science ®Google Scholar
• Koberle B, Tomicic MT, Usanova S, Kaina B. (2010). Cisplatin resistance: preclinical findings and clinical implications. Biochim Biophys Acta 1806:172–82
   PubMed Web of Science ®Google Scholar
• Knipp M. (2009). Metallothioneins and platinum(II) anti-tumor compounds. Current Med Chem 16:522–37
   PubMed Web of Science ®Google Scholar
• Kumar S, Sud N, Fonseca FV, et al. (2010). Shear stress stimulates nitric oxide signaling in pulmonary arterial endothelial cells via a reduction in catalase activity: role of protein kinase C. Am J Physiol Lung Cell Mol Physiol 298:L105–16
   Web of Science ®Google Scholar
• Kutuk O, Arisan ED, Tezil T, et al. (2009). Cisplatin overcomes Bcl-2-mediated resistance to apoptosis via preferential engagement of Bak: critical role of Noxa-mediated lipidperoxidation. Cancer Biol 30:1517–27
   Google Scholar
• Kuzkaya N, Weissmann N, Harrison DG, Dikalov S. (2003). Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase. J Biol Chem 278:22546–54
   PubMed Web of Science ®Google Scholar
• Levine RL, Garland D, Oliver CN, et al. (1990). Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186:464–78
   PubMed Web of Science ®Google Scholar
• Li Z, Khaletskiy A, Wang J, et al. (2001). Genes regulated in human breast cancer cells overexpressing manganese-containing superoxide dismutase. Free Radic Biol Med 30:260–7
   PubMed Web of Science ®Google Scholar
• Londero D, Greco PL. (1996). Automated HPLC separating with spectrofluorometric detection of malondialdehyde-thiobarbituric acid adducts in plasma. J. Chromatogr 729:207–10
   PubMed Web of Science ®Google Scholar
• Ma WD, Yin MY, Jiang CW, et al. (2005). Synergetic cytotoxicity of cisplatin and etoposide to leukemia cell line K562 and its mechanism. Ai Zheng 24:958–64
   PubMedGoogle Scholar
• Mistra HP, Fridovich I. (1972). The role of superoxide anion in the autooxidation of epinephrine and a simple assay for superoxide dismutation. J Biol Chem 247:3170–4
   PubMed Web of Science ®Google Scholar
• Mize CE, Longdon RG. (1962). Hepatic glutathione reductase. I. Purification and general kinetic properties. J Biol Chem 237:1589–95
   PubMed Web of Science ®Google Scholar
• Neuschwander-Tetri BA, Roll FJ. (1989). Glutathione measurement by high-performance liquid chromatography separation and fluorometric detection of the glutathione-orthophthalaldehyde adduct. Anal Biochem 179:236–241
   PubMed Web of Science ®Google Scholar
• Ognjanović BI, Djordjević NZ, Matić MM, et al. (2012). Lipid peroxidative damage on cisplatin exposure and alterations in antioxidant defense system in rat kidneys: a possible protective effect of selenium. J Mol Sci 13:1790–803
   Google Scholar
• Pabla N, Huang S, Mi QS, et al. (2008). ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis. J Biol Chem 283:6572–83
   PubMed Web of Science ®Google Scholar
• Paglia DE, Valentine WN. (1967). Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158–69
   PubMed Web of Science ®Google Scholar
• Pearl LH, Skelly JV, Hudson BD, Neidle S. (1987). The crystal structure of the DNA-binding drug berenil: molecular studies of berenil--DNA complex. Nucleic Acids Res 15:3469–78
   PubMed Web of Science ®Google Scholar
• Peklak-Scott C, Smitherman PK, Townsend AJ, Morrow CS. (2008). The role of glutathione S-transferase P1-1 (GSTP1-1) in the cellular detoxification of cisplatin. Mol Cancer Ther 7:3247–55
   PubMed Web of Science ®Google Scholar
• Pelicano H, Carney D, Huang P. (2004). ROS stress in cancer cells and therapeutic implications. Drug Resistance Updates 7:97–110
   PubMed Web of Science ®Google Scholar
• Pelicano H, Feng L, Zhou Y, et al. (2003). A Novel strategy to enhance drug-induced apoptosis in human leukemia cells by a reactive oxygen species-mediated mechanism. J Biol Chem 278:37832–9
   PubMed Web of Science ®Google Scholar
• Pelicano H, Xu R, Du M, et al. (2006). Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism. J Cell Biol 175:913–23
   PubMed Web of Science ®Google Scholar
• Popławska B, Bielawska A, Surażyński A, et al. (2009). Novel dinuclear platinum (II) complex targets NFκB signaling pathway to induce apoptosis and inhibit metabolism of MCF-7 breast cancer cells. Folia Histochem Cytobiol 47:S141–6
   Web of Science ®Google Scholar
• Rebillard A, Jouan-Lanhouet S, Jouan E, et al. (2010). Cisplatin-induced apoptosis involves a Fas-ROCK-ezrin-dependent actin remodelling in human colon cancer cells. Eur J Cancer 46:1445–55
   PubMed Web of Science ®Google Scholar
• Rice-Evans CA, Diplock AT, Symons MCR. (1991). Techniques in free radical research. In Burdon RH, van Knippenberg PH, eds. Laboratory techniques in biochemistry and molecular biology. Amsterdam: Elsevier, 233--4
   Google Scholar
• Rousseau J, Barth RF, Fernandez M, et al. (2010). Efficacy of intracerebral delivery of cisplatin in combination with photon irradiation for treatment of brain tumors. J Neuro – Onc 98:287–95
   PubMed Web of Science ®Google Scholar
• Rybak LP, Whitworth CA, Mukherjea D, Ramkumar V. (2007). Mechanisms of cisplatin-inducedototoxicity and prevention. Hear Res 226:157–67
   PubMed Web of Science ®Google Scholar
• Schumacker PT. (2006). Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell 1/3:175–6
   Google Scholar
• Schweyer S, Soruri A, Heintze A, et al. (2004). The role of reactive oxygen species in cisplatin-induced apoptosis in human malignant testicular germ cell lines. Int J Oncol 25:1671–6
   PubMed Web of Science ®Google Scholar
• Shulaev V, Oliver DJ. (2006). Metabolic and proteomic markers for oxidative stress. New tools for reactive oxygen species research. Plant Physiol 141:367–72
   PubMed Web of Science ®Google Scholar
• Simons AL, Ahmad IM, Mattson DM, et al. (2007). 2-Deoxy-d-glucose combined with cisplatin enhances cytotoxicity via metabolic oxidative stress in human head and neck cancer cells. Cancer Res 67:3364–70
   PubMed Web of Science ®Google Scholar
• Stankiewicz-Kranc A, Miltyk W, Skrzydlewska E. (2010). Comparison of influence of carmustine and new proline analog of nitrosourea on antioxidant system in breast carcinoma cells (MCF-7). Drug Chem Toxicol 33:55–63
   PubMed Web of Science ®Google Scholar
• Su WC, Chang SL, Chen TY, et al. (2000). Comparison of in vitro growth-inhibitory activity of carboplatin and cisplatin on leukemic cells and hematopoietic progenitors: the myelosuppressive activity of carboplatin may be greater than its antileukemic effect. Jpn J Clin Oncol 30:562–7
   PubMed Web of Science ®Google Scholar
• Sykes JA, McCormac FX, O’Breien TJ. (1978). Preliminary study of the superoxide dismutase content of some human tumors. Cancer Res 38:2759–62
   PubMed Web of Science ®Google Scholar
• Trachootham D, Alexandre J, Huang P. (2009). Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 8:579–91
   PubMed Web of Science ®Google Scholar
• Vataserry GT, Brin MF, Fahn S, et al. (1988). Effects of high doses of dietary vitamin E on the concentrations of vitamin E in several brain regions plasma, liver and adipose tissue of rats. J Neurochem 51:621–3
   PubMed Web of Science ®Google Scholar
• Wang J, Yi J. (2008). Cancer cell killing via ROS: to increase or decrease, that is the question. Cancer Biol therapy 7/12:1875–84
   Web of Science ®Google Scholar
• Witola WH, Inoue N, Ohashi K, Onuma M. (2004). RNA-interference silencing of the adenosine transporter-1 gene in Trypanosoma evansi confers resistance to diminazene aceturate. Exp Parasitol 107:47–57
   PubMed Web of Science ®Google Scholar
• Yoshino K, Matsuura T, Sano M, et al. (1986). Fluorometric liquid chromatographic of aliphatic aldehydes arising from lipid proxides. Chem Pharm Bull 34:1964–700
   Web of Science ®Google Scholar